Artimplant receives ongoing funding for costs related to lawsuits in the U.S.
Artimplant has previously announced its assessment that there is adequate insurance coverage for all injuries alleged in the ongoing trials in the U.S. However it is currently unclear if it falls under Artimplant former or current insurance provider. In the meantime, while the liabilities are determined, an agreement has been made to ensure that Artimplant, for the foreseeable future, receives funding for the costs Artimplant has to run the lawsuits. The costs will thereby not affect Artimplant liquidity. For additional information, please contact:Kjell Thörnbring, CEO, phone +46 (0)